Cargando…
Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial
BACKGROUND: BRCA mutation carriers have a 40-80% life-time risk of developing breast cancer. They may opt for yearly breast cancer surveillance or for prophylactic mastectomy. Both options show increased survival rates. It is a complex choice to be made between these two options. As a result most wo...
Autores principales: | Visser, Annemiek, Prins, Judith B, Hoogerbrugge, Nicoline, van Laarhoven, Hanneke WM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174867/ https://www.ncbi.nlm.nih.gov/pubmed/21864353 http://dx.doi.org/10.1186/1472-6874-11-39 |
Ejemplares similares
-
DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct
por: Sie, Aisha S, et al.
Publicado: (2012) -
Finding all BRCA pathogenic mutation carriers: best practice models
por: Hoogerbrugge, Nicoline, et al.
Publicado: (2016) -
The life in sight application study (LISA): design of a randomized controlled trial to assess the role of an assisted structured reflection on life events and ultimate life goals to improve quality of life of cancer patients
por: Kruizinga, Renske, et al.
Publicado: (2013) -
The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI
por: Vreemann, Suzan, et al.
Publicado: (2018) -
Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study
por: Harmsen, Marline G., et al.
Publicado: (2015)